Analyst action$RMD4:59 PM ET

Macquarie lifts ResMed price target to A$47.50

By BORSA NewsroomPublished Nov 1, 2026, 4:59 PM ESTUpdated Nov 1, 2026, 5:00 PM EST

Macquarie lifted its price target on ResMed to A$47.50 per share, up 1.5%. The adjustment reflects a modest revision in the bank's valuation view.

Sentimentbullish 60

Bullish · 60 of 100

Impact10

low · stays off the top drivers

Confidence60%

moderate confidence · single wire

Eventdeveloping

v1 · alerted to followers

WHAT WE KNOW

Macquarie raised its price target on ResMed to A$47.50 per share.
The increase is 1.5% from the prior target.
Macquarie raised its price target on ResMed to A$47.50 per share, a 1.5% increase from the prior target.